Ozempic, Wegovy to carry new FDA warning over rare risk of vision loss ...Middle East

Popular weight loss drugs including Ozempic and Wegovy will carry a new warning about a possible rare side effect that can sometimes lead to permanent vision loss, US health regulators announced Monday. The Food and Drug Administration said the risk will be added to the labeling of all GLP-1 drugs, the blockbuster medications used to treat obesity, diabetes and several other medical conditions. The class includes a dozen injectable or pill-based drugs, including widely used brands like Zepbound and Mounjaro. The eye condition, known as non-arteritic anterior ischemic optic neuropathy, can cause significant vision loss. The problem, which has been reported with all GLP-1 drugs, is caused by decreased blood flow to the optic nerve, although the underlying cause isn't understood, the FDA said. FDA scientists began looking into the problem after the publication of a 2024 medical paper tying the condition to certain patients taking semaglutide, the active drug in Eli Lilly's Ozempic. An

Hence then, the article about ozempic wegovy to carry new fda warning over rare risk of vision loss was published today ( Tuesday 10/11/2026 - 06:24 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ozempic, Wegovy to carry new FDA warning over rare risk of vision loss )

Also on site :

• Solidion Technology (NASDAQ: STI) Reports Third Quarter Financial Results, Highlighting Strong Cash Balance, Reduction in Liabilities and Positive EPS
• Commerce Dept. Chip Inquiry Was Halted After Nvidia Intervention
• Savings Season Starts Now on AMAZON.SA: Incredible Deals, Unbeatable Value, and Fast Delivery This 11.11